PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | -25.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8 | +60.0% | 50,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.8% | 50,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 50,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -25.0% | 50,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 50,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,200,000 | $858,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 1,856,019 | $724,000 | 0.04% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $39,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 94,500 | $37,000 | 0.02% |
| WADE G W & INC | 80,000 | $31,000 | 0.01% |
| Marcus Capital, LLC | 15,000 | $6,000 | 0.01% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $4,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 28,000 | $11,000 | 0.00% |
| Estate Counselors, LLC | 10,000 | $4,000 | 0.00% |
| Focused Wealth Management, Inc | 2,955 | $1,000 | 0.00% |